- Home
- VERU vs FCO Comparison
VERU vs FCO Comparison
Compare VERU & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- FCO
- Stock Information
- Founded
- VERU 1971
- FCO 1991
- Country
- VERU United States
- FCO United Kingdom
- Employees
- VERU N/A
- FCO N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- FCO Investment Managers
- Sector
- VERU Health Care
- FCO Finance
- Exchange
- VERU Nasdaq
- FCO Nasdaq
- Market Cap
- VERU 76.9M
- FCO 78.3M
- IPO Year
- VERU 1990
- FCO N/A
- Fundamental
- Price
- VERU $0.50
- FCO $6.24
- Analyst Decision
- VERU Strong Buy
- FCO
- Analyst Count
- VERU 2
- FCO 0
- Target Price
- VERU $4.00
- FCO N/A
- AVG Volume (30 Days)
- VERU 856.5K
- FCO 100.1K
- Earning Date
- VERU 05-08-2025
- FCO 01-01-0001
- Dividend Yield
- VERU N/A
- FCO 14.96%
- EPS Growth
- VERU N/A
- FCO N/A
- EPS
- VERU N/A
- FCO 0.43
- Revenue
- VERU $16,886,419.00
- FCO N/A
- Revenue This Year
- VERU N/A
- FCO N/A
- Revenue Next Year
- VERU N/A
- FCO N/A
- P/E Ratio
- VERU N/A
- FCO $12.30
- Revenue Growth
- VERU 134.43
- FCO N/A
- 52 Week Low
- VERU $0.45
- FCO $4.73
- 52 Week High
- VERU $1.42
- FCO $6.63
- Technical
- Relative Strength Index (RSI)
- VERU 44.61
- FCO 58.96
- Support Level
- VERU $0.48
- FCO $6.12
- Resistance Level
- VERU $0.56
- FCO $6.40
- Average True Range (ATR)
- VERU 0.02
- FCO 0.13
- MACD
- VERU -0.00
- FCO 0.01
- Stochastic Oscillator
- VERU 30.83
- FCO 63.64
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.